124 related articles for article (PubMed ID: 11386854)
1. A novel neurodevelopmental syndrome responsive to 5-hydroxytryptophan and carbidopa.
Ramaekers VT; Senderek J; Häusler M; Häring M; Abeling N; Zerres K; Bergmann C; Heimann G; Blau N
Mol Genet Metab; 2001 Jun; 73(2):179-87. PubMed ID: 11386854
[TBL] [Abstract][Full Text] [Related]
2. Effects of L-5-hydroxytryptophan on monoamine and amino acids turnover in the Lesch-Nyhan syndrome.
Castells S; Chakrabarti C; Winsberg BG; Hurwic M; Perel JM; Nyhan WL
J Autism Dev Disord; 1979 Mar; 9(1):95-103. PubMed ID: 312282
[TBL] [Abstract][Full Text] [Related]
3. Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam.
Chadwick D; Hallett M; Harris R; Jenner P; Reynolds EH; Marsden CD
Brain; 1977 Sep; 100(3):455-87. PubMed ID: 412560
[TBL] [Abstract][Full Text] [Related]
4. Serotonin and myoclonus.
Van Woert MH; Jutkowitz R; Rosenbaum D; Bowers MB
Monogr Neural Sci; 1976; 3():71-80. PubMed ID: 790170
[TBL] [Abstract][Full Text] [Related]
5. Long-term therapy of myoclonus and other neurologic disorders with L-5-hydroxytryptophan and carbidopa.
Van Woert MH; Rosenbaum D; Howieson J; Bowers MB
N Engl J Med; 1977 Jan; 296(2):70-5. PubMed ID: 401457
[TBL] [Abstract][Full Text] [Related]
6. Autism associated with low 5-hydroxyindolacetic acid in CSF and the heterozygous SLC6A4 gene Gly56Ala plus 5-HTTLPR L/L promoter variants.
Adamsen D; Meili D; Blau N; Thöny B; Ramaekers V
Mol Genet Metab; 2011 Mar; 102(3):368-73. PubMed ID: 21183371
[TBL] [Abstract][Full Text] [Related]
7. Clinical and metabolic observations on the treatment of myoclonus with L-5-HTP and carbidopa.
Thal L; Sharpless N; Wolfson L; Engel J; Katzman R
Trans Am Neurol Assoc; 1976; 101():48-52. PubMed ID: 1088459
[No Abstract] [Full Text] [Related]
8. Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486.
Van Woert MH; Sethy VH
Neurology; 1975 Feb; 25(2):135-40. PubMed ID: 1078720
[TBL] [Abstract][Full Text] [Related]
9. Secondary neurotransmitter deficiencies in epilepsy caused by voltage-gated sodium channelopathies: A potential treatment target?
Horvath GA; Demos M; Shyr C; Matthews A; Zhang L; Race S; Stockler-Ipsiroglu S; Van Allen MI; Mancarci O; Toker L; Pavlidis P; Ross CJ; Wasserman WW; Trump N; Heales S; Pope S; Cross JH; van Karnebeek CD
Mol Genet Metab; 2016 Jan; 117(1):42-8. PubMed ID: 26647175
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous determination of tryptophan, 5-hydroxytryptophan, 5-hydroxytryptamine, 5-hydroxyindoleacetic acid, 4-hydroxy-3-methoxyphenylacetic acid and 3-methoxy-4-hydroxyphenylglycol in human cerebrospinal fluid.
Yi YH; Liao WP; Lu X
J Chromatogr B Biomed Appl; 1994 Nov; 661(1):143-8. PubMed ID: 7532522
[TBL] [Abstract][Full Text] [Related]
11. Study of serotonin in neuropsychiatric disorders.
Van Woert MH; Magnussen I; Lowe YH; Hwang EC
J Histochem Cytochem; 1982 Aug; 30(8):824-7. PubMed ID: 6181125
[No Abstract] [Full Text] [Related]
12. Disorder in the serotonergic system due to tryptophan hydroxylation impairment: a cause of hypothalamic syndrome?
Schott DA; Nicolai J; de Vries JE; Keularts IM; Rubio-Gozalbo ME; Gerver WJ
Horm Res Paediatr; 2010; 73(1):68-73. PubMed ID: 20190542
[TBL] [Abstract][Full Text] [Related]
13. [Malignant phenylketonuria caused by biopterin synthetase deficiency. Study of neuromediator catabolites in the cerebrospinal fluid during treatment].
Malpuech G; Guyon A; Demeocq F; Piton A; Boespflug O; Vanlieferinghen P
Arch Fr Pediatr; 1984 Jan; 41(1):5-8. PubMed ID: 6202269
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of serotonin precursors in postanoxic action myoclonus.
De Léan J; Richardson JC; Hornykiewicz O
Neurology; 1976 Sep; 26(9):863-8. PubMed ID: 1084968
[TBL] [Abstract][Full Text] [Related]
15. Improved strength on 5-hydroxytryptophan and carbidopa in spinal cord atrophy.
Horvath GA; Meisner L; Selby K; Stowe R; Carleton B
J Neurol Sci; 2017 Jul; 378():59-62. PubMed ID: 28566180
[TBL] [Abstract][Full Text] [Related]
16. Improvement of Self-Injury With Dopamine and Serotonin Replacement Therapy in a Patient With a Hemizygous PAK3 Mutation: A New Therapeutic Strategy for Neuropsychiatric Features of an Intellectual Disability Syndrome.
Horvath GA; Tarailo-Graovac M; Bartel T; Race S; Van Allen MI; Blydt-Hansen I; Ross CJ; Wasserman WW; Connolly MB; van Karnebeek CDM
J Child Neurol; 2018 Jan; 33(1):106-113. PubMed ID: 29246092
[TBL] [Abstract][Full Text] [Related]
17. Biogenic amine synthesis defect in dihydropteridine reductase deficiency.
Koslow SH; Butler IJ
Science; 1977 Nov; 198(4316):522-3. PubMed ID: 20665
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid alterations of the serotonin product, 5-hydroxyindolacetic acid, in neurological disorders.
De Grandis E; Serrano M; Pérez-Dueñas B; Ormazábal A; Montero R; Veneselli E; Pineda M; González V; Sanmartí F; Fons C; Sans A; Cormand B; Puelles L; Alonso A; Campistol J; Artuch R; García-Cazorla A
J Inherit Metab Dis; 2010 Dec; 33(6):803-9. PubMed ID: 20852934
[TBL] [Abstract][Full Text] [Related]
19. Characterization of mutations in severe methylenetetrahydrofolate reductase deficiency reveals an FAD-responsive mutation.
Sibani S; Leclerc D; Weisberg IS; O'Ferrall E; Watkins D; Artigas C; Rosenblatt DS; Rozen R
Hum Mutat; 2003 May; 21(5):509-20. PubMed ID: 12673793
[TBL] [Abstract][Full Text] [Related]
20. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events.
D'Angelo A; Coppola A; Madonna P; Fermo I; Pagano A; Mazzola G; Galli L; Cerbone AM
Thromb Haemost; 2000 Apr; 83(4):563-70. PubMed ID: 10780318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
